VLA 0.00% $1.75 viralytics limited

Ann: Viralytics to Present New CAVATAK Clinical Data at AACR, page-2

  1. 12,177 Posts.
    lightbulb Created with Sketch. 1080
    Hi,
    Two Podium presentations and one Poster.
    Impressive this could be the turning point and the start of a rerate of VLA technology.
    I thought Malcolm would make this announcement.
    Aloha.
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.